October 2015

New Product - Pergoveris

Pergoveris (follitropin alfa (rch) and lutropin alfa (rch)) is indicated for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials, these patients were defined by an endogenous serum LH of less than 1.2 IU/L. Pergoveris is contraindicated in ovarian, uterine or mammary carcinoma; tumours of the hypothalamus or pituitary gland; ovarian enlargement or cyst of unknown aetiology; gynaecological haemorrhages of unknown origin; in pregnancy and lactation. Pergoveris (follitropin alfa 150 IU and lutropin alfa 75 IU) is available as a powder for injection in vials of 1’s.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au